Skip to main content

Table 1 ACR indicates American College of Rheumatology; AJC, active joint count; DI-CHAQ, disability index of childhood health assessment questionnaire; PaGA, parent global assessment of well-being; PhyGA, physician’s global assessment of disease activity.

From: Long-term efficacy and safety of adalimumab in 4-12 year old patients with juvenile idiopathic arthritis

Time points

ACR 30/50/70/90

PhyGA

PaGA

AJC

DI-CHAQ

Week 16

100/88/63/39

12.7

12.2

5.1

0.4

Week 48

100/96/92/69

6.3

8.3

2.9

0.2

Week 106

100/96/96/71

5.9

5.0

1.2

0.1

  1. % of Pts Aged 4-12 Years Achieving ACR Pedi and Mean Values in Disease Activity/Severity Variables by ADA Exposure Throughout the Study
Back to article page

Pediatric Rheumatology

ISSN: 1546-0096